Filing Flows

Filing Flows › Merck (MRK) › Recalls, complaints & regulation

Merck (MRK): recalls, EPA violations, clinical trials and Federal Register

Merck (MRK) beyond its filings: 2 recalls in the last 12 months (5 in five years, 1 Class I); 5 EPA-regulated facilities in violation, $43K in penalties over five years; 10 Federal Register documents in a year; 238 active clinical trials.

Latest recalls

EPA facilities in violation

Facility (as registered)CityStatusPenalties
MERCK SHARP & DOHME - KENILWORTHKenilworth, NJViolation Identified$18K
MERCK-SHARP DOHMEBarceloneta, PRViolation—
MERCK SHARP & DOHME CORPORATIONDurham, NCViolation—
MERCK SHARP & DOHME CORPRahway, NJViolation Identified—
MERCK SHARP & DOHME CORPWest Trenton, NJViolation Identified—

Facilities in the EPA's ECHO register whose registered name matches the company's; a facility can belong to another business of the same name.

Merck's latest quarter

Merck, Q3 2026: revenue $18.1B (+5% year over year), operating margin 30.7%, net earnings $5.1B, operating cash flow $6.6B. The chart follows the revenue to costs, profit and cash.

Questions

Has Merck had any recalls?

5 recalls on file over five years from the FDA, CPSC and NHTSA; 2 in the last 12 months.

Has Merck been fined by the EPA?

The 46 EPA-regulated facilities on file under its name drew $43K in penalties over five years; 5 are in violation now.

How many clinical trials does Merck have?

238 active studies on ClinicalTrials.gov, 110 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.